Join us for the sixth installment of the NEALS webinar series on ALS drug development moderated by Dr. Richard Bedlack from the Duke ALS Clinic. This series will include talks on the preclinical development of potential therapies, the regulatory pathway, the science of trials, ethical considerations, the clinical trial site level overview, and the importance of research engagement by people living with ALS.

In this webinar, Dr. Bedlack and Dr. Cudkowicz will discuss why research engagement by people living with ALS is important, examples of how it is helping, continued challenges, and plans for further improvements in the future.